Sort   by:  
 Page size 
UnknownEvaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.
Not available
S-EPMC5839400 | biostudies-literature
UnknownOutcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis.
Not available
S-EPMC12757519 | biostudies-literature
UnknownPrimary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas.
Not available
S-EPMC4376730 | biostudies-literature
UnknownAllogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy.
Not available
S-EPMC7830938 | biostudies-literature
UnknownResponse to: Ruxolitinib withdrawal due to the COVID-19.
Not available
S-EPMC7905976 | biostudies-literature
UnknownNeutrophil-to-Lymphocyte ratio as surrogate for JAK2<sup>V617F</sup> suppression and event-free survival in polycythemia vera.
Not available
S-EPMC12328675 | biostudies-literature
UnknownRapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL.
Not available
S-EPMC11053125 | biostudies-literature
UnknownCost-utility analysis of ropeginterferon alfa-2b to manage low-risk patients with polycythemia vera as compared to phlebotomy only in the Austrian healthcare system.
Not available
S-EPMC11868240 | biostudies-literature
UnknownEffect of trauma on asylum seekers and refugees receiving a WHO psychological intervention: a mediation model.
Not available
S-EPMC11149571 | biostudies-literature
UnknownRuxolitinib for the prevention of thrombosis in polycythemia vera: a systematic review and meta-analysis.
Not available
S-EPMC6988397 | biostudies-literature
Sort   by:  
 Page size